RSS-Feed abonnieren
DOI: 10.1055/s-2005-873192
© Georg Thieme Verlag KG Stuttgart · New York
Antimicrobial Principle from Aframomum longifolius
Dr. Ikhlas A. Khan
National Center for Natural Products Research
The University of Mississippi
University
MS 38677-1848
USA
Fax: +1-662-915-7989
eMail: ikhan@olemiss.edu
Publikationsverlauf
Received: October 17, 2004
Accepted: July 18, 2005
Publikationsdatum:
05. Dezember 2005 (online)
Abstract
Antimicrobial activity-directed fractionation of the seeds of Aframomum longifolius (Zingiberaceae) afforded two new labdane-type diterpenoids, 15-hydroxy-15-methoxylabda-8(17), 12(E)-dien-16-al (aframolin A) (1) and 8β(17)-epoxy-15,15-dimethoxylabd-12(E)-en-16-al (aframolin B) (2), together with the known diterpenes labda-8(17),12(E)-diene-15,16-dial (3) and aframodial (4). Their structures were determined by spectroscopic methods. Compound 4 showed significant antimicrobial activity against Cryptococcus neoformans, Staphylococcus aureus and methicillin-resistant S. aureus (MRS) while 1, 2 and 3 were found to be inactive.
#Introduction
Many species of Aframomum (Zingiberaceae) are used in Cameroon for medicinal, ethnodietary and spiritual purposes [1]. The genus Aframomum was found to contain flavonoids and diterpenoids [1], [2], [3]. Aframodial, a diterpene dialdehyde isolated from Aframomum daniellii (Hook. F.) K. Shum [2] was reported to possess antifungal, cytotoxic and hypercholesterolemic properties [4], [5]. Although plants of this genus find an extensive use in folklore medicine, no phytochemical study has so far been reported on A. longifolius. We herein report an antimicrobial activity-guided fractionation of the seeds of this plant.
#Materials and Methods
#General experimental procedures
NMR spectra, including COSY, HMQC, DEPT and HMQC experiments, were recorded on a Varian Mercury 400 or a Bruker DRX 500 spectrometer at 400 or 500 MHz (1H) and 100 or 125 MHz (13C), with chemical shifts given in ppm (δ) using TMS as an internal standard. IR spectra were recorded on an ATI Mattson Genesis Series FTIRTM. MS were recorded either on a Hewlett Packard 5890 Series II, GC/MS, Finnigan AQA or Brucker Biopex FTMS. Optical rotations were measured on a Rudolph Research Analytical (Autopol IV) automatic polarimeter. Silica gel, 40 μm (flash chromatography packing; 6 Å pore diameter) was used for CC, silica gel 60 F254 (Merck) was used for TLC, and silica gel GF was used for preparative TLC.
#Plant material
The seeds of A. longifolius were collected in September 2002 at Koladom, a village situated 12 km from Ebolowa, South Cameroon and authenticated by Dr. Zapfack of the Botany Department, University of Yaounde I, Cameroon. A voucher specimen (UD 516) is deposited at the herbarium of the Botany Department of the University of Dschang, Cameroon.
#Extraction and isolation
The seeds of A. longifolius (284 g) were macerated three times with a methylene chloride/methanol mixture (1 : 1, 600 mL × 3). Filtration and removal of solvent under vacuum afforded 62 g of crude extract. This extract was loaded on a silica gel column (7 × 50 cm, 600 g) and eluted with hexane-EtOAc (19 : 1, 7 L; 9 : 1, 3 L; 17 : 3, 2.5 L; 4 : 1, 1.75 L; 7 : 3, 1.75 L; 3 : 2, 3.25 L; 2 : 3, 2.25 L) to obtain 170 fractions (125 mL each). The fractions were combined into nine major fractions (F1 - F9, F1 : 1 - 20, F2 : 21 - 56, F3 : 56 - 68, F4 : 69 - 92, F5 : 93 - 100, F6 : 101 - 114, F7 : 115 - 139, F8 : 140 - 153, F9 : 154 - 170) based on TLC behavior. IC50 values of active fractions are summarized in Table [1]. F1, F7, F8 and F9 were found to be inactive. Fraction F2 (4.6 g) was chromatographed on a silica gel column (4 × 40 cm, 60 g) eluting with hexane-EtOAc (39 : 1, 2.7 L) to yield four subfractions: B1 (1.5 L), B2 (0.5 L), B3 (0.3 L), B4 (0.4 L). Subfraction B1 was further chromatographed on a silica gel column (2 × 30 cm, 15 g) using hexane-Et2O (9 : 1, 1 L) as eluent to yield compound 1 (10.6 mg). Subfraction B4 was purified on a chromatotron with hexane-EtOAc (10 : 0, 39 : 1, 19 : 1, 33 : 3, 0.5 L each) to give compound 3 (9.1 mg). Fraction F3 (3.2 g) was loaded on a silica gel column (3 × 45 cm, 50 g) using hexane-EtOAc (9 : 1, 17 : 3, 4 : 1, 3 : 1, 7 : 3, 0.5 L each) to yield 4 (80.1 mg). Part of fraction F4 (3.5 g) was chromatographed on silica gel column (3 × 45 cm, 50g) using hexane-EtOAc (9 : 1, 17 : 3, 4 : 1, 3 : 1, 7 : 3, 0.5 L each) to yield 4 (70.5 mg). Subfractions from F4 were further purified by preparative TLC with hexane-EtOAc (2 : 3) to obtain 2 (38 mg). Fraction F5 (1.5 g) was loaded on a silica gel column (4 × 45 cm, 60 g) using hexane-EtOAc (9 : 1, 17 : 3, 4 : 1, 3 : 1, 7 : 3, 1.5 L each) as eluent to yield 134.5 mg of 4.
Fractions | IC50 (μg/mL) | |||
Candida albicans | C. neoformansb | S. aureusc | MRSd | |
F2 | 65 | 15 | 90 | 50 |
F3 | 70 | < 8 | 65 | 50 |
F4 | 65 | < 8 | 65 | 20 |
F5 | 70 | 9.0 | 60 | 15 |
F6 | - | 15 | - | - |
Amphotericin Be | 0.20 | 0.35 | NT | NT |
Ciprofloxacinf | NT | NT | 0.15 | 0.10 |
a For extracts and column fractions an IC50 < = 150 μg/mL is considered active for further fractionation. | ||||
b Cryptococcus neoformans. | ||||
c Staphylococcus aureus. | ||||
d Methicillin-resistant Staphylococcus aureus. | ||||
e Compound used as drug control for antifungal tests. | ||||
f Compound used as drug control for antibacterial tests. | ||||
NT = not tested; - = not active. |
Isolates
Aframolin A (1): Colorless oil; [α]D 27: 8.33° (c 0.24; CHCl3); IR (CHCl3): νmax = 3380, 1680, 1464, 1125, 1077, 978, 750 cm-1; EI-MS: m/z (rel. int.) = 316 [M - 18]+ (5), 258 (9), 137 (11), 122 (14), 91 (8), 75 (100), 47 (13), 41 (15); HR-ESI-MS: m/z = 357.2389 [M + Na]+ (calcd.: 357.2405); 1H-NMR (CDCl3, 400 MHz): δ = 0.74 (3H, s, H-20), 0.82 (3H, s, H-19), 0.88 (3H, s, H-18), 1.14 (1H, dd, J = 12.8, 2.4 Hz, H-5), 1.89 (1H, brd, J = 10.8 Hz, H-9), 2.60 (2H, dd, J = 6.0, 3.6 Hz, H-14), 2.65 (2H, dd, J = 6.4, 3.2 Hz, H-11), 3.34 (3H, s, OMe-15), 4.41 (1H, d, J = 1.6 Hz, H-17′), 4.43 (1H, t, J = 6.0 Hz, H-15), 4.83 (1H, d, J = 1.6 Hz, H-17), 6.54 (1H, t, J = 6.4 Hz, H-12), 9.33 (1H, s, H-16); 13C-NMR (CDCl3, 100 MHz): δ = 14.6 (C-20), 19.5 (C-2), 21.9 (C-19), 24.3 (C-6), 24.7 (C-11), 29.2 (C-14), 33.7 (C-18), 33.8 (C-4), 38.1 (C-7), 39.4 (C-1), 39.8 (C-10), 42.2 (C-3), 54.5 (OMe), 55.6 (C-5), 56.7 (C-9), 104.1 (C-15), 108.1 (C-17), 138.3 (C-13), 148.4 (C-8), 160.2 (C-12), 195.2 (C-16).
Aframolin B (2): Colorless oil; [α]D 26: 22.2° (c 1.44; CHCl3); IR (CHCl3): νmax = 2928, 2843, 1681, 1461, 1388, 1121, 1077, 973, 756 cm-1; LR-ESI: m/z = 382 [M + NH4]+, 365 [M + H]+; HR-ESI-MS: m/z = 387.2509 [M + Na]+ (calcd.: 387.2505); 1H-NMR (CDCl3, 400 MHz): δ = 0.88 (3H, s, H-19), 0.91 (3H, s, H-18), 0.95 (3H, s, H-20), 1.04 (1H, dd, J = 11.6, 2.8 Hz, H-5), 1.66 (1H, brd, J = 8.0 Hz, H-9), 2.30, 2.49 (each 1H, d, J = 4.0 Hz, H-17), 2.55 (2H, dd, J = 8.8, 5.2 Hz, H-14), 3.32 (6H, s, 2 × OMe-15), 4.28 (1H, t, J = 5.2 Hz, H-15), 6.47 (1H, t, J = 6.8 Hz, H-12), 9.35 (1H, s, H-16); 13C-NMR (CDCl3, 100 MHz): δ = 14.9 (C-20), 18.8 (C-2), 20.2 (C-6), 21.9 (C-19), 22.2 (C-11), 29.0 (C-14), 33.7 (C-18), 33.7 (C-4), 36.0 (C-7), 39.4 (C-1), 40.0 (C-10), 42.1 (C-3), 49.0 (C-17), 53.1 (C-9), 54.1 (OMe), 54.3 (OMe), 55.2 (C-5), 57.8 (C-8), 103.6 (C-15), 138.5 (C-13), 160.6 (C-12), 194.8 (C-16).
#Antimicrobial assay
All organisms were obtained from the American Type Culture Collection (Manassas, VA) and included Candida albicans ATCC 90 028, Cryptococcus neoformans ATCC 90 113, Staphylococcus aureus ATCC 29 213, and methicillin-resistant S. aureus ATCC 43 300 (MRS). Susceptibility testing was performed using a modified version of the National Committee on Clinical Laboratory Standards (NCCLS) methods [6], [7], [8]. Samples (dissolved in DMSO) were serially-diluted using 0.9 %/20 % saline/DMSO and transferred in duplicate to 96-well microplates. Microbial inocula were prepared after comparison of the OD630 of cell suspensions to the 0.5 McFarland standard and diluting the suspensions in broth Sabouraud Dextrose and cation-adjusted Mueller-Hinton (Difco) for the fungi and bacteria, respectively, to afford recommended inocula. Microbial inocula were added to the samples to achieve a final volume of 200 μL and final sample concentrations starting with 20 - 50 μg/mL. Growth, solvent and media controls were included on each test plate. All organisms were read at 630 nm prior to and after incubation. Percent growth was calculated and plotted versus test concentration to afford the IC50.
#Results and Discussion
The dichloromethane-methanol (1 : 1) extract of seeds of A. longifolius exhibited significant activities against Candida albicans, C. neoformans, S. aureus and MRS, with IC50 values of 20, 9, 40 and 25 μg/mL, respectively. Bioassay-guided fractionation of the crude extract and purification of the active fractions led to the isolation of compounds 1 - 4.[*]
Compound 1 was obtained as a colorless oil, molecular formula C21H34O3, based on HR-ESI-MS, m/z = 357.2389 [M + Na]+ (calcd.: 357.2405). The 13C-NMR spectrum exhibited 21 carbon signals, including four methyls (among which is one methoxy group), eight methylenes, five methines and four quaternary carbons. The 1H-NMR and IR spectra indicated the presence of an α,β-unsaturated aldehyde (δH = 9.33; ν = 1680 cm-1) [9]. This was evident from the 13C-NMR spectrum wherein one olefinic carbon appeared at δC = 160.2 and the aldehyde carbon at δC = 195.2. Further examination of the 1H-NMR spectrum revealed a signal for an olefinic proton at δH = 6.54 and an exocyclic methylene group at δH = 4.41 and 4.83. The remaining signals of the 1H- and 13C-NMR suggested a labdane skeleton for 1 [5], [9], [10], [11]. The structure of the side-chain C-11 to C-16 was assigned by a combination of HMQC and HMBC experiments. The HMQC spectrum enabled to assign each proton to the corresponding carbon. In the HMBC spectrum (Fig. [1]), pertinent correlations were observed between H-12 at δH = 6.74 (1H, t, J = 6.4 Hz) and C-9 (δC = 56.7), C-14 (δC = 29.2), and C-16 (δC = 195.2). In addition, protons at δH = 2.60 (2H, dd, J = 6.0, 3.6 Hz, H-14) and δH = 3.34 (3H, s, OMe) were correlated with the methine carbon at δC = 104.1 (C-15). Accordingly, the structure of the side-chain showed great resemblance with that of labda-8(17),12(E)-dien-15,16-dial (3) [5], [9], [10] also isolated. They differed at position 16 where the aldehyde group is replaced by a hemiacetal group in 1. Thus, compound 1 was determined as 15-hydroxy-15-methoxylabda-8(17),12(E)-dien-16-al. The new compound was named aframolin A. Aframolin A is a demethylated derivative of calcaratarin A, isolated from Alpinia calcarata [11].
Compound 2, colorless oil, was assigned the molecular formula C22H36O4 based on HR-ESI-MS, m/z = 387.2509 [M + Na]+ (calcd.: 387.2505). Its 1H-NMR and IR spectra suggested the presence of an α,β-unsaturated aldehyde (δH = 9.35, ν = 1681 cm-1) [9]. The 1H- and 13C-NMR spectra showed signals characteristic of an 8(17)-epoxylabdane-type diterpenoid [1], [10]. The 8(17)-epoxide was indicated by the carbon signals at δC = 49.0 (C-17) and 57.8 (C-8). The spectral data of 2 were almost similar to those of aframodial (4) [5], [9], [10], also isolated. The 1H-NMR of 2 compared to that of aframodial (4), displayed only one aldehyde proton at δH = 9.35 (s), one methine at δH = 4.28 (t, J = 5.2 Hz) and two methoxys at δH = 3.32. Based on HMBC correlations, the proton at δH = 4.28 was assigned to position 15, since it showed correlation with the two methoxy carbons at δC = 54.1 and 54.3, and the methylene at δC = 29.0 (C-14). The HMBC correlations are depicted in Fig. [1]. Thus, compound 2 was established as 8β(17)-epoxy-15,15-dimethoxylabd-12(E)-en-16-al. The new compound was named aframolin B.
Two known diterpenes were identified as labda-8(17),12(E)-dien-15,16-dial (3) and aframodial (4) from their spectral data [5], [9], [10].
The antimicrobial activity of the isolates had been evaluated, and compounds 1 - 3 did not show any appreciable activity. However, compound 4 showed significant activity against C. neoformans, S. aureus and MRS with IC50/MIC 6.0/20, 10/20 and 10/20 μg/mL, respectively.


Fig. 1 HMBC correlations of compounds 1 and 2.
Acknowledgements
We gratefully acknowledge financial support from the ICBG ”Drug Development and Conservation in West and Central Africa” Grant No TW03004 from the Fogarty Centre, NIH. Materials have been reviewed by the Walter Reed Army Institute of Research, Washington DC, USA. We thank Dr. P. V. Srinivas, National Center for Natural Products Research, The University of Mississippi, for assistance in the interpretation of some spectral data.
#References
- 1 Tomla C, Kamnaing P, Ayimele G A, Tanifum E A, Tsopmo A, Tane P. et al . Three labdane diterpenoids from Aframomum sceptum (Zingiberaceae). Phytochemistry. 2002; 60 197-200
- 2 Kimbu S F, Njini T K, Sondengam B L, Akinniyi J A, Connolly J D. The structure of labdane dialdehyde from Aframomum daniellii (Zingiberaceae). J Chem Soc Perkin Trans I 1979: 1303-4
- 3 Tsopmo A, Ayimele G A, Tane P, Ayafor J F, Connolly J D, Sterner O. A norbislabdane and other labdanes from Aframomum sulcatum . Tetrahedron. 2002; 58 2725-8
- 4 Masahiro T, Yuh-Dan C, Ken-ichi S, Yoshihiro K. Cholesterol biosynthesis inhibitory component from Zingiber officinale Roscoe. Chem Pharm Bull. 1993; 41 710-3
- 5 Morita H, Itokawa H. Cytotoxic and antifungal diterpenes from the seeds of Alpinia galanga . Planta Med. 1988; 54 117-20
- 6 Pfaller M A, Chaturvedi V, Espinel-Ingroff A, Ghannoum M A, Gosey L L, Odds F C. et al . Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, M27-A2. National Committee on Clinical Laboratory Standards. 2002; 22 1-51
- 7 Pfaller M A, Chaturvedi V, Espinel-Ingroff A, Ghannoum M A, Gosey L L, Odds F C. et al . Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Approved standard, M-38A. National Committee on Clinical Laboratory Standards. 2002; 22 1-30
- 8 Ferraro M J, Craig W A, Dudley M N, Eliopoulos G M, Hecht D W, Hindler J. et al . Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, M7-A5. National Committee on Clinical Laboratory Standards. 2000; 20 1-58
- 9 Morita H, Itokawa H. New diterpenes from Alpinia galanga wild. Chem Lett. 1986; 7 1205-8
- 10 Ngo K, Brown G D. Stilbenes, monoterpenes, diarylheptanoids, labdanes and chalcones from Alpinia katsumadai . Phytochemistry. 1998; 47 1117-23
- 11 Kong L, Qin M, Niwa M. Diterpenoids from the rhizomes of Alpinia calcarata . J Nat Prod. 2000; 63 939-42
Dr. Ikhlas A. Khan
National Center for Natural Products Research
The University of Mississippi
University
MS 38677-1848
USA
Fax: +1-662-915-7989
eMail: ikhan@olemiss.edu
References
- 1 Tomla C, Kamnaing P, Ayimele G A, Tanifum E A, Tsopmo A, Tane P. et al . Three labdane diterpenoids from Aframomum sceptum (Zingiberaceae). Phytochemistry. 2002; 60 197-200
- 2 Kimbu S F, Njini T K, Sondengam B L, Akinniyi J A, Connolly J D. The structure of labdane dialdehyde from Aframomum daniellii (Zingiberaceae). J Chem Soc Perkin Trans I 1979: 1303-4
- 3 Tsopmo A, Ayimele G A, Tane P, Ayafor J F, Connolly J D, Sterner O. A norbislabdane and other labdanes from Aframomum sulcatum . Tetrahedron. 2002; 58 2725-8
- 4 Masahiro T, Yuh-Dan C, Ken-ichi S, Yoshihiro K. Cholesterol biosynthesis inhibitory component from Zingiber officinale Roscoe. Chem Pharm Bull. 1993; 41 710-3
- 5 Morita H, Itokawa H. Cytotoxic and antifungal diterpenes from the seeds of Alpinia galanga . Planta Med. 1988; 54 117-20
- 6 Pfaller M A, Chaturvedi V, Espinel-Ingroff A, Ghannoum M A, Gosey L L, Odds F C. et al . Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, M27-A2. National Committee on Clinical Laboratory Standards. 2002; 22 1-51
- 7 Pfaller M A, Chaturvedi V, Espinel-Ingroff A, Ghannoum M A, Gosey L L, Odds F C. et al . Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Approved standard, M-38A. National Committee on Clinical Laboratory Standards. 2002; 22 1-30
- 8 Ferraro M J, Craig W A, Dudley M N, Eliopoulos G M, Hecht D W, Hindler J. et al . Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, M7-A5. National Committee on Clinical Laboratory Standards. 2000; 20 1-58
- 9 Morita H, Itokawa H. New diterpenes from Alpinia galanga wild. Chem Lett. 1986; 7 1205-8
- 10 Ngo K, Brown G D. Stilbenes, monoterpenes, diarylheptanoids, labdanes and chalcones from Alpinia katsumadai . Phytochemistry. 1998; 47 1117-23
- 11 Kong L, Qin M, Niwa M. Diterpenoids from the rhizomes of Alpinia calcarata . J Nat Prod. 2000; 63 939-42
Dr. Ikhlas A. Khan
National Center for Natural Products Research
The University of Mississippi
University
MS 38677-1848
USA
Fax: +1-662-915-7989
eMail: ikhan@olemiss.edu


Fig. 1 HMBC correlations of compounds 1 and 2.